Hong Lu,* Yanmei Mao,* Ying Zeng, Pengyu Li, Pan Yan, Qunzhi Shi, Lin Liu Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, People’s Republic of China*These ...
Lu H +6 more
doaj
Purpose We aimed to investigated the influencing risk factors of voriconazole-induced liver injury in Uygur pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Methods This was a prospective cohort design study.
Ting Zhao +6 more
doaj +1 more source
Voriconazole-Induced acute interstitial pulmonary edema with angioedema: A case report
Background Voriconazole is a first-line antifungal agent for invasive fungal infections. Reports of voriconazole-induced interstitial pulmonary edema are exceedingly rare.
Yuzhen Jin +4 more
doaj +1 more source
Clinical characteristics, treatment, and outcomes of fungal keratitis/endophthalmitis caused by <i>Purpureocillium lilacinum</i>. [PDF]
Hu L +6 more
europepmc +1 more source
The Global Antifungal Susceptibility Epidemiology of Trichophyton indotineae Indicating Voriconazole as an Alternative Therapy for Recalcitrant Dermatophytosis. [PDF]
Song G +5 more
europepmc +1 more source
Evaluation of corneal intrastromal voriconazole injection as an adjuvant approach in recalcitrant fungal keratitis. [PDF]
Said KEG, Aggour NM, Basiony AI.
europepmc +1 more source
Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy. [PDF]
Wehbe E +17 more
europepmc +1 more source
Case Report: Invasive pulmonary aspergillosis caused by <i>Aspergillus lentulus</i> in a boy with chronic granulomatous disease. [PDF]
Tan S, Liao Q, Wen Y, Zhu Y.
europepmc +1 more source
Interpretation of Pharmacometabolomics Results: Fingerprint of Drug Exposure or Confounder Effects? Insights from a Urinary Metabolomics Study with Voriconazole in Healthy Participants. [PDF]
Chobanyan-Jürgens K +10 more
europepmc +1 more source

